切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2019, Vol. 13 ›› Issue (05) : 454 -457. doi: 10.3877/cma.j.issn.1674-3946.2019.05.009

所属专题: 文献

论著

腹腔镜辅助右半结肠癌D3根治术临床安全性及可行性研究
姜慧员1, 刘海义1, 白文启1, 王文渊1, 梁艳杰2, 王艳3, 江波1,()   
  1. 1. 030012 太原,山西省肿瘤医院结直肠肛门外科
    2. 030012 太原,山西省肿瘤医院检验科
    3. 030012 太原,山西省肿瘤医院病因室
  • 收稿日期:2019-02-08 出版日期:2019-10-26
  • 通信作者: 江波

Clinical safety and feasibility of laparoscopic D3 radical resection for right colon cancer

Huiyuan Jiang1, Haiyi Liu1, Wenqi Bai1, Wenyuan Wang1, Yanjie Liang2, Yan Wang3, Bo Jiang1,()   

  1. 1. Department of Colorectal and Anal Surgery, Shanxi Cancer Hospital, Shanxi 030012, China
    2. Department of Laboratory, Shanxi Cancer Hospital, Shanxi 030012, China
    3. Department of Etiology, Shanxi Cancer Hospital, Shanxi 030012, China
  • Received:2019-02-08 Published:2019-10-26
  • Corresponding author: Bo Jiang
  • About author:
    Corresponding author: Jiang Bo, Email:
  • Supported by:
    Basic Research Projects of Natural Science of Shanxi Science and Technology Department(NO.2017JM8160)
引用本文:

姜慧员, 刘海义, 白文启, 王文渊, 梁艳杰, 王艳, 江波. 腹腔镜辅助右半结肠癌D3根治术临床安全性及可行性研究[J/OL]. 中华普外科手术学杂志(电子版), 2019, 13(05): 454-457.

Huiyuan Jiang, Haiyi Liu, Wenqi Bai, Wenyuan Wang, Yanjie Liang, Yan Wang, Bo Jiang. Clinical safety and feasibility of laparoscopic D3 radical resection for right colon cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2019, 13(05): 454-457.

目的

探究腹腔镜辅助右半结肠癌D3根治术的临床疗效。

方法

回顾性分析2013年1月至2018年10月60例右半结肠癌患者资料,均行右半结肠癌D3根治术。2013年1月至2015年6月30例患者为开腹组;2015年7月至2018年10月30例患者为腹腔镜组。采用统计学软件SPSS 20.0进行数据分析,围术期指标、炎性反应及免疫功能指标采用(±s)表示,独立t检验;并发症等计数资料采用χ2检验;P<0.05差异有统计学意义。

结果

腹腔镜组在手术时间方面长于开腹组,在术中出血量、术后排气排便时间、肠鸣音恢复时间、下床时间及住院时间等方面均优于开腹组(P<0.05)。两组患者术前WBC、CRP及血清胃泌素(GS)水平差异无统计学意义(P>0.05),术后均明显增加,但腹腔镜组低于开腹组(P<0.05)。两组患者术前CD4、CD8、CD4/CD8比较无统计学意义(P>0.05);术后均有所改善,但腹腔镜组患者的CD4、CD4/CD8较开腹组明显增高,CD8较开腹组明显降低(P<0.05)。两组患者术后并发症比较无统计学意义(P>0.05)。

结论

腹腔镜辅助右半结肠癌D3根治术术中创伤小、出血少,术后恢复快,安全可行。

Objective

To explore the clinical effect of laparoscopic D3 radical resection for right colon cancer.

Methods

Data of 60 patients with right hemicolon cancer in our hospital from January 2013 to October 2018 were retrospectively analyzed, all of whom underwent right hemicolon cancer D3 radical resection. From January 2013 to June 2015, 30 patients were divided into the open group. 30 patients from July 2015 to October 2018 were divided into the laparoscopic group. Statistical software SPSS 20.0 was used for data analysis. Statistical software SPSS 20.0 was used for data analysis. Measurement data such as perioperative relevant indicators , inflammatory response and immune function indicators were expressed as (±s) and were examined by independent t test. The incidence of complications were examined by chi square test. A P value of <0.05 was considered as statistically significant.

Results

Compare with Open group, there was longer operation time, less intraoperative blood loss, quicker postoperative exhaust and defecation time, earlier intestinal rumbling recovery time, shorter time to get out of bed and hospitalization in the Laparoscopic group, with statistically significant differences respectively(P<0.05). There were no significant differences in terms of preoperative WBC, CRP and serum gastrin (GS) levels between two groups (P>0.05). There was no significant difference of preoperative CD4, CD8 and CD4/CD8 between the two groups (P>0.05), but the CD4 and CD4/CD8 in laparoscopic group were significantly higher than those in open group, and CD8 was significantly lower than that in open group (P<0.05). There was no significant difference of postoperative complications between the two groups (P>0.05).

Conclusion

Laparoscopic D3 radical resection for right colon cancer is safe and feasible with less trauma, less bleeding and rapid recovery.

表1 60例右半结肠癌患者不同术式两组患者一般资料情况[(±s),例]
表2 60例右半结肠癌患者不同术式两组患者围术期指标比较(±s)
表3 60例右半结肠癌患者不同术式两组患者两组术后并发症情况(例)
表4 60例右半结肠癌患者不同术式两组患者手术前后炎性反应及GS水平比较(±s)
表5 60例右半结肠癌患者不同术式手术前后两组免疫功能变化情况(±s)
[1]
Pilozzi E,Lorenzon L,Lo Baido S, et al. Left-sided early onset colorectal carcinomas: A sporadic neoplasm with aggressive behavior[J]. Am J Surg, 2017, 214(3): 421-427.
[2]
郑民华,马君俊.腹腔镜右半结肠癌根治术的难点与争议[J/CD].中华普外科手术学杂志(电子版),2018,12(3): 181-184.
[3]
郑民华.腹腔镜结直肠癌手术并发症的预防与处理原则[J/CD].中华普外科手术学杂志:电子版,2014, 8(2): 101-104.
[4]
张尚文,刘小飞,徐锋.腹腹腔镜下中间入路右半结肠癌D3根治术的临床应用[J].中国医药科学,2016,6(3): 213-216.
[5]
王海家,葛晓伟,孟宏春.开腹右半结肠癌根治术与腹腹腔镜辅助右半结肠癌根治术的效果比较分析[J].中国现代医生,2018,56(25): 51-54.
[6]
尹林,黄客增,蔡尚坤.腹腹腔镜与传统开腹根治术治疗右半结肠癌临床疗效的对比分析[J].实用癌症杂志,2016,31(10): 1669-1671.
[7]
朱玮,吕成余,曹红勇.右半结肠癌顺、逆行性淋巴结清扫术术后疗效比较[J].湖南师范大学学报(医学版),2018,15(6): 42-44.
[8]
肖毅,徐徕,陆君阳.腹腔镜右半结肠癌切除淋巴结清扫范围及意义[J/CD].中华普外科手术学杂志(电子版),2018,12(3): 185-188.
[9]
杜晓辉,何长征.右半结肠癌微创治疗的术式选择[J].临床外科杂志,2018,26(10): 724-726.
[10]
董昌利,刘延锋,王铎.老年右半结肠癌行腹腹腔镜完整结肠系膜切除术的近期疗效评价[J/CD].中华普外科手术学杂志(电子版),2018,12(5): 404-406.
[11]
陈健.腹腔镜右半结肠癌根治术治疗结肠癌对患者胃肠功能及预后情况的影响[J].实用医院临床杂志,2018,15(1): 26-28.
[12]
刘作良,谢雪虹,田洪鹏,等.腹腹腔镜直肠癌根治术后并发症影响因素分析[J].中国普外基础与临床杂志,2018,25(12): 1482-1486.
[13]
张泉,邱思芳,赵逵,等.结直肠癌及腺瘤患者CD4+、CD8+和CD28+T淋巴细胞的亚群变化及临床意义[J].中国癌症杂志,2018,28(8): 577-583.
[14]
钟俊斌,杨平,孙政,等.腹腹腔镜辅助右半结肠癌根治术与传统开腹术对免疫功能及疗效的临床观察[J].广州医药,2017,48(2): 99-101.
[1] 张启龙, 柳亿, 卢会丽, 罗慧, 李成林, 王菁, 王辉. 奥妥珠单抗治疗磷脂酶A2受体相关膜性肾病的疗效与安全性:单中心回顾性分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 379-384.
[2] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[3] 王振宁, 杨康, 王得晨, 邹敏, 归明彬, 王雅楠, 徐明. 机器人与腹腔镜手术联合经自然腔道取标本对中低位直肠癌患者远期疗效比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 437-442.
[4] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[5] 崔宏帅, 冯丽明, 东维玲, 韩博. 腹腔镜右半结肠癌D3根治术+IGLN清扫术治疗局部进展期结肠肝曲癌的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 566-569.
[6] 丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[7] 王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[8] 王浩源, 汪海洋, 孙建明, 陈以宽, 祁小桐, 唐博. 腹腔镜与开放修补对肝硬化腹外疝患者肝功能及凝血的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 654-659.
[9] 王鹏, 邵欣欣, 胡海涛, 田艳涛, 钟宇新. 改良MOBS 吻合法在全腹腔镜近端胃大部分切除中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 267-270.
[10] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[11] 关国欣, 罗福文. 结肠癌合并急性梗阻的个性化处理[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 459-463.
[12] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[13] 陶金华, 陈珊珊, 陈晓四. 阿帕替尼联合替吉奥治疗晚期食管癌的疗效与安全性影响因素评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 325-329.
[14] 靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
[15] 傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.
阅读次数
全文


摘要